tiprankstipranks
Advertisement
Advertisement

MNOV Stock Latest News

Medicinova: Buy Rating Reiterated as Pipeline Advances and Cash Runway Extends, $6 Price Target Maintained
RatingsMedicinova: Buy Rating Reiterated as Pipeline Advances and Cash Runway Extends, $6 Price Target Maintained
3d ago
MNOV
MediciNova’s peer-reviewed ibudilast study advances clinical translation
PremiumThe Fly
MediciNova’s peer-reviewed ibudilast study advances clinical translation
27d ago
MNOV
Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
2M ago
BIP
BOX
Maxim resumes MediciNova at Buy on potential value-driving data events this year
PremiumThe Fly
Maxim resumes MediciNova at Buy on potential value-driving data events this year
2M ago
MNOV
MediciNova resumed with a Buy at Maxim
PremiumThe Fly
MediciNova resumed with a Buy at Maxim
2M ago
MNOV
MediciNova initiated with a Buy at H.C. Wainwright
PremiumThe FlyMediciNova initiated with a Buy at H.C. Wainwright
2M ago
MNOV
MediciNova management to meet with Maxim
Premium
The Fly
MediciNova management to meet with Maxim
3M ago
MNOV
MediciNova issues letter to shareholders
Premium
The Fly
MediciNova issues letter to shareholders
5M ago
MNOV
MediciNova initiated with a Buy at Lucid Capital
PremiumThe Fly
MediciNova initiated with a Buy at Lucid Capital
5M ago
MNOV
MediciNova Establishes Flexible At-The-Market Equity Program
PremiumCompany Announcements
MediciNova Establishes Flexible At-The-Market Equity Program
5M ago
8K
MNOV
MediciNova completes patient enrollment in neuropathy trial of MN-166
PremiumThe Fly
MediciNova completes patient enrollment in neuropathy trial of MN-166
5M ago
MNOV
MediciNova files $300M mixed securities shelf
PremiumThe Fly
MediciNova files $300M mixed securities shelf
6M ago
MNOV
MediciNova names Dr. Christopher Breder as Clinical and Regulatory Advisor
PremiumThe FlyMediciNova names Dr. Christopher Breder as Clinical and Regulatory Advisor
6M ago
MNOV
MediciNova completes patient enrollment in MN-001-NATG-202 trial
Premium
The Fly
MediciNova completes patient enrollment in MN-001-NATG-202 trial
7M ago
MNOV
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
Premium
The Fly
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
7M ago
MNOV
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
PremiumThe Fly
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
8M ago
MNOV
MediciNova provides update on SEPA, COMBAT-ALS trial enrollment
PremiumThe Fly
MediciNova provides update on SEPA, COMBAT-ALS trial enrollment
9M ago
MNOV
MediciNova achieves enrollment in COMBAT-ALS clinical trial
PremiumThe Fly
MediciNova achieves enrollment in COMBAT-ALS clinical trial
9M ago
MNOV
MediciNova files to sell 25M shares of common stock for holders
PremiumThe Fly
MediciNova files to sell 25M shares of common stock for holders
9M ago
MNOV
MediciNova Secures $30 Million Equity Purchase Agreement
PremiumCompany AnnouncementsMediciNova Secures $30 Million Equity Purchase Agreement
10M ago
8K
MNOV
MediciNova enters $30M equity purchase agreement
Premium
The Fly
MediciNova enters $30M equity purchase agreement
10M ago
MNOV
MediciNova provides enrollment update for two key ongoing clinical trials
Premium
The Fly
MediciNova provides enrollment update for two key ongoing clinical trials
10M ago
MNOV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >